Since B cells participate in both innate and adaptive immune functions, functions which are modulated by IFN-β [17] and contribute to MS pathogenesis, it is of interest to delineate the cellular pathways triggered by IFN-β in B cells of patients with MS. The gene discussed is IFNB1; the disease is myeloid sarcoma.